187 related articles for article (PubMed ID: 7875683)
1. Expression of SPARC in normal and fibrotic livers.
Frizell E; Liu SL; Abraham A; Ozaki I; Eghbali M; Sage EH; Zern MA
Hepatology; 1995 Mar; 21(3):847-54. PubMed ID: 7875683
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus-mediated inhibition of SPARC attenuates liver fibrosis in rats.
Camino AM; Atorrasagasti C; Maccio D; Prada F; Salvatierra E; Rizzo M; Alaniz L; Aquino JB; Podhajcer OL; Silva M; Mazzolini G
J Gene Med; 2008 Sep; 10(9):993-1004. PubMed ID: 18615449
[TBL] [Abstract][Full Text] [Related]
3. Osteonectin (SPARC) expression in human liver and in cultured human liver myofibroblasts.
Blazejewski S; Le Bail B; Boussarie L; Blanc JF; Malaval L; Okubo K; Saric J; Bioulac-Sage P; Rosenbaum J
Am J Pathol; 1997 Sep; 151(3):651-7. PubMed ID: 9284812
[TBL] [Abstract][Full Text] [Related]
4. Interferon gamma inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: implications for treatment of hepatic fibrosis.
Rockey DC; Chung JJ
J Investig Med; 1994 Dec; 42(4):660-70. PubMed ID: 8521029
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of secreted protein acidic and rich in cystein in esophageal carcinoma and its relation to carcinoma progression.
Yamashita K; Upadhay S; Mimori K; Inoue H; Mori M
Cancer; 2003 May; 97(10):2412-9. PubMed ID: 12733139
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of osteonectin by human retinal pigment epithelial cells is modulated by cell density.
Magee RM; Hagan S; Hiscott PS; Sheridan CM; Carron JA; McGalliard J; Grierson I
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2707-11. PubMed ID: 10937587
[TBL] [Abstract][Full Text] [Related]
7. Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis.
Iredale JP; Benyon RC; Arthur MJ; Ferris WF; Alcolado R; Winwood PJ; Clark N; Murphy G
Hepatology; 1996 Jul; 24(1):176-84. PubMed ID: 8707259
[TBL] [Abstract][Full Text] [Related]
8. Type I collagen-deficient Mov-13 mice do not retain SPARC in the extracellular matrix: implications for fibroblast function.
Iruela-Arispe ML; Vernon RB; Wu H; Jaenisch R; Sage EH
Dev Dyn; 1996 Oct; 207(2):171-83. PubMed ID: 8906420
[TBL] [Abstract][Full Text] [Related]
9. Expression of leptin and leptin receptor during the development of liver fibrosis and cirrhosis.
Otte C; Otte JM; Strodthoff D; Bornstein SR; Fölsch UR; Mönig H; Kloehn S
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):10-7. PubMed ID: 14758566
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis of soluble factors secreted by limbal fibroblasts.
Shimmura S; Miyashita H; Higa K; Yoshida S; Shimazaki J; Tsubota K
Mol Vis; 2006 May; 12():478-84. PubMed ID: 16710172
[TBL] [Abstract][Full Text] [Related]
11. SPARC gene expression is increased in diabetes-related mesenteric vascular hypertrophy.
Jandeleit-Dahm K; Rumble J; Cox AJ; Kelly DJ; Dziadek M; Cooper ME; Gilbert RE
Microvasc Res; 2000 Jan; 59(1):61-71. PubMed ID: 10625572
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of type I procollagen C-proteinase enhancer protein messenger RNA in rats with CCl4-induced liver fibrosis.
Ogata I; Auster AS; Matsui A; Greenwel P; Geerts A; D'Amico T; Fujiwara K; Kessler E; Rojkind M
Hepatology; 1997 Sep; 26(3):611-7. PubMed ID: 9303490
[TBL] [Abstract][Full Text] [Related]
13. Entactin gene expression in normal and fibrotic rat liver and in rat liver cells.
Schwoegler S; Neubauer K; Knittel T; Chung AE; Ramadori G
Lab Invest; 1994 Apr; 70(4):525-36. PubMed ID: 8176891
[TBL] [Abstract][Full Text] [Related]
14. Increased levels of SPARC (osteonectin) in human breast cancer tissues and its association with clinical outcomes.
Watkins G; Douglas-Jones A; Bryce R; Mansel RE; Jiang WG
Prostaglandins Leukot Essent Fatty Acids; 2005 Apr; 72(4):267-72. PubMed ID: 15763438
[TBL] [Abstract][Full Text] [Related]
15. Small interfering RNA inhibition of SPARC attenuates the profibrotic effect of transforming growth factor beta1 in cultured normal human fibroblasts.
Zhou X; Tan FK; Guo X; Wallis D; Milewicz DM; Xue S; Arnett FC
Arthritis Rheum; 2005 Jan; 52(1):257-61. PubMed ID: 15641096
[TBL] [Abstract][Full Text] [Related]
16. SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma.
Lau CP; Poon RT; Cheung ST; Yu WC; Fan ST
J Pathol; 2006 Dec; 210(4):459-68. PubMed ID: 17029219
[TBL] [Abstract][Full Text] [Related]
17. Gamma-Linolenic acid regulates the expression and secretion of SPARC in human cancer cells.
Watkins G; Martin TA; Bryce R; Mansel RE; Jiang WG
Prostaglandins Leukot Essent Fatty Acids; 2005 Apr; 72(4):273-8. PubMed ID: 15763439
[TBL] [Abstract][Full Text] [Related]
18. The expression of SPARC in adipose tissue and its increased plasma concentration in patients with coronary artery disease.
Takahashi M; Nagaretani H; Funahashi T; Nishizawa H; Maeda N; Kishida K; Kuriyama H; Shimomura I; Maeda K; Hotta K; Ouchi N; Kihara S; Nakamura T; Yamashita S; Matsuzawa Y
Obes Res; 2001 Jul; 9(7):388-93. PubMed ID: 11445660
[TBL] [Abstract][Full Text] [Related]
19. Regulation of secreted protein acidic and rich in cysteine during adipose conversion and adipose tissue hyperplasia.
Chavey C; Boucher J; Monthouël-Kartmann MN; Sage EH; Castan-Laurell I; Valet P; Tartare-Deckert S; Van Obberghen E
Obesity (Silver Spring); 2006 Nov; 14(11):1890-7. PubMed ID: 17135603
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of SPARC and its impact on proliferation and apoptosis in ADPKD cyst-lining epithelia.
Wang W; Mei C; Tang B; Zhao H; Xu C; Li Z; Shen X; Fu W; Dai B
Nephrol Dial Transplant; 2006 May; 21(5):1278-88. PubMed ID: 16421164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
